Abstract
This study examined differences by age in service use and associated expenditures during 2005 for Medicaid-enrolled children with autism spectrum disorders. Aging was associated with significantly higher use and costs for restrictive, institution-based care and lower use and costs for community-based therapeutic services. Total expenditures increased by 5 % with each year of age; by 23 % between 3–5 and 6–11 year olds, 23 % between 6–11 and 12–16, and 14 % between 12–16 and 17–20 year olds. Use of and expenditures for long-term care, psychiatric medications, case management, medication management, day treatment/partial hospitalization, and respite services increased with age; use of and expenditures for occupational/physical therapy, speech therapy, mental health services, diagnostic/assessment services, and family therapy declined.
Similar content being viewed by others
References
Aman, M., Lam, K., et al. (2003). Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. Journal of Autism and Developmental Disorders, 33(5), 527–534.
Amendah, D., Grosse, S., et al. (2011). The economic costs of autism: A review. In D. Amaral, G. Dawson, & D. Geschwind (Eds.), Autism spectrum disorders. New York: Oxford University Press.
CMS (2011). Report on state services to individuals with autism spectrum disorders. Centers for Medicare & Medicaid Services ASD Services Project.
Croen, L., Najjar, D., et al. (2006). A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics, 118(4), e1203–1211.
Fombonne, E., Heavey, L., et al. (2004). Validation of the diagnosis of autism in general practitioner records. BMC Public Health, 4(Article 5).
Ganz, M. (2006). The costs of autism. In S. Moldin & J. Rubenstein (Eds.), Understanding autism: From basic neuroscience to treatment Boca Raton. FL: CRC Press.
Ganz, M. (2007). The lifetime distribution of the incremental societal costs of autism. Archives of Pediatrics and Adolescent Medicine, 161(4), 343–349.
Grether, J., Rosen, N., et al. (2009). Investigation of shifts in autism reporting in the California department of developmental services. Journal of Autism and Developmental Disorders, 39(10), 1412–1419.
Gurney, J., McPheeters, M., et al. (2006). Parental report of health conditions and health care use among children with and without autism: National survey of children’s health. Archives of Pediatrics and Adolescent Medicine, 160(8), 825–830.
Howlin, P., & Goode, S. (1998). Outcome in adult life for individuals with autism. In F. Volkmar (Ed.), Autism and developmental disorders. New York: Cambridge University Press.
Howlin, P., Goode, S., et al. (2004). Adult outcome for children with autism. Journal of Child Psychology and Psychiatry, 45(2), 212–237.
Kang, T., & Harrington, C. (2008). Variation in types of service use and expenditures for individuals with developmental disabilities. Disability and Health Journal, 1(1), 30–41.
Leslie, D., & Martin, A. (2007). Health care expenditures associated with autism spectrum disorders. Archives of Pediatrics and Adolescent Medicine, 161(4), 350–355.
Levy, S. E., Giarelli, E., et al. (2010). Autism spectrum disorder and co-occurring developmental, psychiatric, and medical conditions among children in multiple populations of the United States. Journal of Developmental and Behavioral Pediatrics, 31(4), 267–275.
Liptak, G., Stuart, T., et al. (2006). Health care utilization and expenditures for children with autism: Data from US national samples. Journal of Autism and Developmental Disorders, 36, 871–879.
Logan, S., Nicholas, J., et al. (2012). High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network. Annals of Epidemiology, 22(1), 1–8.
Lokhandwala, T., Khanna, R., et al. (2012). Hospitalization burden among individuals with autism. Journal of Autism and Developmental Disorders, 42(1), 95–104.
Lord, C., Risi, S., et al. (2006). Autism from 2 to 9 years of age. Archives of General Psychiatry, 63(6), 649–701.
Lurie, N., Popkin, M., et al. (1992). Accuracy of diagnoses of schizophrenia in Medicaid claims. Hospital & Community Psychiatry, 43(1), 69–71.
Mandell, D. (2008). Psychiatric hospitalization among children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 38(6), 1059–1065.
Mandell, D., Cao, J., et al. (2006). Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999. Journal of Autism and Developmental Disorders, 36(4), 475–485.
Mandell, D., Listerud, J., et al. (2002). Race differences in the age at diagnosis among Medicaid-eligible children with autism. Journal of the American Academy of Child and Adolescent Psychiatry, 41(12), 1447–1453.
Mandell, D., Machefsky, A., et al. (2008a). Medicaid’s role in financing health care for children with behavioral health care needs in the special education system: Implications of the deficit reduction act. Journal of School Health, 78(10), 532–538.
Mandell, D., Morales, K., et al. (2008b). Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121(3), E441–E448.
Mandell, D., Xie, M., et al. (2012). The interplay of outpatient services and psychiatric hospitalization among Medicaid-enrolled children with autism spectrum disorders. Archives of Pediatrics and Adolescent Medicine, 166(1), 68–73.
Newschaffer, C., & Curran, L. (2003). Autism: An emerging public health problem. Public Health Reports, 118(5), 393–399.
Oswald, D., & Sonenklar, N. (2007a). Medication use among children with autism spectrum disorders. J Child Adolesc Psychopharmacol, 17(3), 348–355.
Oswald, D. P., & Sonenklar, N. A. (2007b). Medication use among children with autism-spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 17(3), 348–355.
Peacock, G., Amendah, D., et al. (2012). Autism spectrum disorders and health care expenditures: The effects of co-occurring conditions. Journal of Developmental and Behavioral Pediatrics, 33(1), 2–8.
Pruchno, R. A., & McMullen, W. F. (2004). Patterns of service utilization by adults with a developmental disability: Type of service makes a difference. American Journal on Mental Retardation, 109(5), 362–378.
Rosenberg, R. E., Mandell, D. S., et al. (2010). Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007–2008. Journal of Autism and Developmental Disorders, 40(3), 342–351.
Ruble, L., Heflinger, C., et al. (2005). Access and service use by children with autism spectrum disorders in Medicaid managed care. Journal of Autism and Developmental Disorders, 35(1), 3–13.
Seltzer, M., Shattuck, P., et al. (2004). Trajectory of development in adolescents and adults with autism. Mental Retardation and Developmental Disabilities Research Reviews, 10, 234–347.
Shattuck, P., Seltzer, M., et al. (2006). Change in autism symptoms and maladaptive behaviors in adolescents and adults with an autism spectrum disorder. Journal of Autism and Developmental Disorders, 37, 1735–1747.
Shattuck, P., Seltzer, M., et al. (2007). Change in autism symptoms and maladaptive behaviors in adolescents and adults with an autism spectrum disorder. Journal of Autism and Developmental Disorders, 37, 1735–1747.
Shattuck, P., Wagner, M., et al. (2011). Post-high school service use among young adults with an autism spectrum disorder. Archives of Pediatrics and Adolescent Medicine, 165(2), 141–146.
Shimabukuro, T., Grosse, S., et al. (2008). Medical expenditures for children with an autism spectrum disorder in a privately insured population. Journal of Autism and Developmental Disorders, 38(3), 546–552.
Stahmer, A., & Mandell, D. (2007). State infant/toddler program policies for eligibility and services provision for young children with autism. Administration and Policy in Mental Health, 34(1), 29–37.
Tidmarsh, L., & Volkmar, F. (2003). Diagnosis and epidemiology of autism spectrum disorders. Canadian Journal of Psychiatry, 48, 517–525.
USDHHS (2009). Medicaid managed care encounter data: Collection and use. United States Department of Health and Human Services Office of Inspector General.
Wang, L., & Leslie, D. (2011). Psychotropic medication use among children with autism spectrum disorder: A comparison between Medicaid and commercial insurance. Value in Health, 14(3), A189–A189.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cidav, Z., Lawer, L., Marcus, S.C. et al. Age-Related Variation in Health Service Use and Associated Expenditures Among Children with Autism. J Autism Dev Disord 43, 924–931 (2013). https://doi.org/10.1007/s10803-012-1637-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-012-1637-2